A un anno da impianto microchip, leggono fino a 12 righe in più
Risultati per: Gestione della malattia di Crohn
Questo è quello che abbiamo trovato per te
Linea guida sulla diagnosi, monitoraggio e gestione dell’asma
Quinta malattia, miocardite per 32 bimbi in Italia e 8 decessi
Dati Ecdc da inizio anno. “Non sottovalutare dolore al petto”
Peristomal Erosion in a Man With Crohn Disease
A man in his 50s with a 10-year history of Crohn disease had intermittent bowel obstructions leading to total proctocolectomy and ileostomy, and 5 weeks after surgery he developed a painful, erosive lesion around his stoma on the anterior abdominal wall. What is your diagnosis?
Raccomandazioni EULAR per la gestione dell’artrite reumatoide con farmaci antireumatici sintetici e biologici modificanti la malattia
Diagnosi e gestione della Leucemia Mieloide Cronica (LMC) negli adulti
Linee guida EAN sulla gestione della sclerosi laterale amiotrofica (SLA)
Preclinical protein signatures of Crohn’s disease and ulcerative colitis: A nested case-control study within large population-based cohorts
Biomarkers are needed to identify individuals at elevated risk of inflammatory bowel disease (IBD). This study aims to identify protein signatures predictive of IBD.
Better Together: Implementing a Multidisciplinary Approach to Optimizing Diagnosis and Management of Crohn’s Perianal Fistulas
Crohn’s perianal fistula (CPF) is an aggressive phenotype of Crohn’s disease (CD) that remains challenging to diagnose and treat, with profound effects on quality of life (QOL). CPF affects approximately 25% of the 780,000 people in the United States living with CD.1 Patients with CPF, only one-third of whom attain long-term remission,2 have higher rates of hospitalizations, surgical intervention, and health care costs than those with isolated luminal CD, as well as significantly increased levels of morbidity, disability, and mental health deterioration.
Schizofrenia, scoperta la firma neurale della malattia
Connessioni uniche cervello pazienti viste con speciale tecnica
Diabetologi, riconoscere come malattia il diabete 1 asintomatico
Senza DRG, i pazienti non hanno accesso a farmaci e monitoraggio
Diabetologi, riconoscere come malattia il diabete 1 asintomatico
Senza DRG, i pazienti non hanno accesso a farmaci e monitoraggio
Marsh Italia, gestione del rischio per una sanità più sicura
Araldi, ‘con MedMal Report identifichiamo aree più a rischio’